I am not going to provide links back to the discussion on patents mainly involving jcurve and myself, but want to add that an "adverse" decision with respect to BTX1503 patentability may well, IMO, strengthen the BTX1503 FDA moat.
I am not going to provide links back to the discussion on...
-
- There are more pages in this discussion • 9,116 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $751.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.0¢ | 40.5¢ | $3.179M | 7.658M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83000 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 367540 | 8 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |